Foto de stock - plitidepsin, has a much more potent antiviral efficacy against SARS-CoV-2 than the only antiviral approved to date, conceptual image.

Imagen: plitidepsin, has a much more potent antiviral efficacy against SARS-CoV-2 than the only antiviral approved to date, conceptual image.

Criterios de búsqueda

Selecciona varios criterios